Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,579 | -6,421 | -4,466 | -1,992 | -10,394 |
| Depreciation Amortization | 1,245 | 918 | 603 | 300 | 1,742 |
| Accounts receivable | 128 | 129 | 142 | 105 | -30 |
| Other Working Capital | -884 | -806 | -290 | -482 | -260 |
| Other Operating Activity | 235 | -28 | -313 | -561 | 1,125 |
| Operating Cash Flow | $-7,855 | $-6,208 | $-4,324 | $-2,630 | $-7,817 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -20 |
| Other Investing Activity | 666 | 666 | 666 | 666 | 0 |
| Investing Cash Flow | $666 | $666 | $666 | $666 | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -15 |
| Common Stock Issued | 496 | 496 | 496 | 496 | N/A |
| Other Financing Activity | 6,750 | 5,250 | 3,250 | 1,750 | 5,976 |
| Financing Cash Flow | $7,246 | $5,746 | $3,746 | $2,246 | $5,961 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 1 |
| Beginning Cash Position | 577 | 577 | 577 | 577 | 2,452 |
| End Cash Position | 634 | 781 | 665 | 859 | 577 |
| Net Cash Flow | $57 | $204 | $88 | $282 | $-1,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,855 | -6,208 | -4,324 | -2,630 | -7,817 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -20 |
| Free Cash Flow | -7,855 | -6,208 | -4,324 | -2,630 | -7,837 |